Status:
TERMINATED
Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
Lead Sponsor:
Ministry of Health & Welfare, Korea
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The primary purpose of this study is to investigate the effectiveness of antidepressants on the treatments for non-psychotic major depressive disorder (MDD) in Korea. The study divides MDD patients in...
Detailed Description
Patients will be classified into 3 levels by their past therapeutic histories: Level 1: Patients who do not receive an appropriate treatment for their current major depressive episode. Level 2: Pati...
Eligibility Criteria
Inclusion
- Clinical diagnosis of non-psychotic Major depressive disorder
- HAMD-17 score 14 or greater
- Age of 18 or greater and 65 or less
Exclusion
- patients with current or past history of diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, or psychotic disorder NOS
- patients with current psychotic features, eating disorders or obsessive-compulsive disorder
- patients with neurological disorder
- patients with medical condition that could interfere with everyday life activities
- pregnant or lactating women,
- patients with current other DSM-IV TR Axis I diagnosis other than MDD which needs inpatient care
- patients who treated with ECT for current depressive episode
- insufficient information of past treatment for current depressive episode
- patients who posed a serious suicidal risk.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
692 Patients enrolled
Trial Details
Trial ID
NCT00926835
Start Date
May 1 2009
End Date
July 1 2015
Last Update
September 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical research center for depression
Seoul, Seoul, South Korea, 150713